Drug-induced liver disease in 2006

被引:26
|
作者
Arundel, Cherinne [1 ]
Lewis, James H. [1 ]
机构
[1] Georgetown Univ, Med Ctr, Sect Hepatol, Div Gastroenterol, Washington, DC 20007 USA
关键词
acetaminophen; drug-induced liver injury; hepatotoxicity; Hy's law;
D O I
10.1097/MOG.0b013e3280b17dfb
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose of review To identify the key publications of 2006 dealing with drug-induced liver injury. Recent findings When given in therapeutic doses over 14 days, acetaminophen produced significant asymptomatic elevations in alanine aminotransferase among healthy volunteers, suggesting that subclinical injury may be more common than previously thought. Acute liver failure in children was shown to differ in several important respects from that seen in adults, notably a much lower incidence of acetaminophen toxicity with nearly half of all cases being indeterminate in origin. The first cases of hepatotoxicity with telithromycin, a new class of ketolide antibiotic, were described along with reports suggesting liver injury from ezetimibe among other agents. The potential for chronic injury to develop after acute drug-induced liver injury was analyzed in a large Swedish database; 5-6% of cases were judged to become chronic, with drugs causing cholestatic injury predominating. Among well described hepatotoxins, new reports appeared with highly active antiretroviral therapy agents, herbal therapies and several antibiotics. Finally, the safe use of pravastatin and pioglitazone was demonstrated in patients with chronic liver disease in controlled clinical trials. Summary Drug-induced liver injury remains an important concern for many existing drugs as well as for agents in development.
引用
收藏
页码:244 / 254
页数:11
相关论文
共 50 条
  • [31] Drug-induced liver disease in 2003
    Pishvaian, AC
    Trope, BW
    Lewis, JH
    CURRENT OPINION IN GASTROENTEROLOGY, 2004, 20 (03) : 208 - 219
  • [32] DRUG-INDUCED LIVER-DISEASE
    MATTIE, H
    BREIMER, DD
    JANSSENS, AR
    NETHERLANDS JOURNAL OF MEDICINE, 1981, 24 (01): : 44 - 44
  • [33] Mechanisms of drug-induced liver disease
    DeLeve, LD
    Kaplowitz, N
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1995, 24 (04) : 787 - &
  • [34] Drug-Induced Fatty Liver Disease
    Niharika Samala
    Naga Chalasani
    Current Hepatology Reports, 2018, 17 (3) : 260 - 269
  • [35] DRUG-INDUCED LIVER-DISEASE
    ZIMMERMAN, HJ
    DRUGS, 1978, 16 (01) : 25 - 45
  • [36] HISTOPATHOLOGY OF DRUG-INDUCED LIVER DISEASE
    SMETANA, HF
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1963, 104 (03) : 821 - &
  • [37] Drug-induced liver disease related to citalopram
    Neumann, Helmut
    Csepregi, Antal
    Evert, Matthias
    Malfertheiner, Peter
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 28 (02) : 254 - 255
  • [38] DRUG-INDUCED CHRONIC LIVER-DISEASE
    MADDREY, WC
    BOITNOTT, JK
    GASTROENTEROLOGY, 1977, 72 (06) : 1348 - 1353
  • [39] Drug-Induced Liver Disease: Clinical Course
    Saithanyamurthi, Hemamala
    Faust, Alison Jazwinski
    CLINICS IN LIVER DISEASE, 2017, 21 (01) : 21 - 34
  • [40] DRUG-INDUCED LIVER DISEASE - A PENALTY FOR PROGRESS
    POPPER, H
    RUBIN, E
    GARDIOL, D
    SCHAFFNER, F
    PARONETTO, F
    ARCHIVES OF INTERNAL MEDICINE, 1965, 115 (02) : 128 - +